MRK 1Q19 items… PR: https://s21.q4cdn.com/488056881/files/doc_financials/2019/Merck-News-Release-04-30-19-Merck-Announces-First-Quarter-2019-Financial-Results.pdf CC slides: https://investors.merck.com/files/doc_financials/2019/MRK-Q1-2019-Earnings-Presentation.pdf 1Q19 Keytruda sales were $2.27B, +55% YoY and +6% QoQ. MRK raised 2019 non-GAAP EPS guidance to $4.67-4.79 (from the prior range of $4.57-4.72).